CIK 0001568651 · Large accelerated filer
Oscar Health, Inc.
Sign in to watch- Ticker
- OSCR
- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (646) 403-3677
- Business address
- 75 VARICK STREET, 5TH FLOOR, NEW YORK, NY, 10013
- Former names
- Oscar Health, Inc., Mulberry Health Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,761,671
- in 8 filings, $3.3M under 10b5-1 plans
Net −$26,761,671. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-27 | Schlosser Mario Director | Conversion | +600,000 | 1,080,866 | ||
| 2026-08-27 | Schlosser Mario Director | Sale | −600,000 | $30.34 | $18.2M | 480,866 |
| 2026-08-27 | Schlosser Mario Director | Option exercise · Stock Option (Right to Buy) | −600,000 | 3,140,000 | ||
| 2026-08-27 | Schlosser Mario Director | Option exercise · Class B Common Stock | +600,000 | $9.75 | $5.8M | 1,812,293 |
| 2026-08-27 | Schlosser Mario Director | Conversion · Class B Common Stock | −600,000 | 1,212,293 | ||
| 2026-08-18 | Blackley Richard Scott Chief Financial Officer | Sale | −18,750 | $31.74 | $595K | 56,250 |
| 2026-07-09 | Gassen William Director | Grant or award · Deferred Stock Unit | +684 | $31.20 | $21K | 7,071 |
| 2026-07-09 | Plouffe David Director | Grant or award · Deferred Stock Unit | +681 | $31.20 | $21K | 7,535 |
| 2026-07-09 | Sankaran Sid Director | Grant or award · Deferred Stock Unit | +858 | $31.20 | $27K | 2,061 |
| 2026-07-01 | Schlosser Mario Director | Conversion 10b5-1 | +47,500 | 47,500 | ||
| 2026-07-01 | Schlosser Mario Director | Sale 10b5-1 | −3,600 | $29.50 | $106K | 43,900 |
| 2026-07-01 | Schlosser Mario Director | Sale 10b5-1 | −13,672 | $30.80 | $421K | 30,228 |
| 2026-07-01 | Schlosser Mario Director | Sale 10b5-1 | −30,228 | $31.65 | $957K | 0 |
| 2026-07-01 | Schlosser Mario Director | Conversion · Class B Common Stock 10b5-1 | −47,500 | 538,333 | ||
| 2026-06-30 | Bertolini Mark T Chief Executive Officer | Sale 10b5-1 | −488,654 | $28.35 | $13.9M | 7,887,160 |
| 2026-06-30 | Bertolini Mark T Chief Executive Officer | Sale 10b5-1 | −135,590 | $28.97 | $3.9M | 7,751,570 |
| 2026-06-29 | Bertolini Mark T Chief Executive Officer | Sale 10b5-1 | −555,826 | $29.17 | $16.2M | 8,434,740 |
| 2026-06-29 | Bertolini Mark T Chief Executive Officer | Sale 10b5-1 | −58,926 | $30.08 | $1.8M | 8,375,814 |
| 2026-06-26 | Bertolini Mark T Chief Executive Officer | Sale 10b5-1 | −441,373 | $29.11 | $12.8M | 9,140,361 |
| 2026-06-26 | Bertolini Mark T Chief Executive Officer | Sale 10b5-1 | −149,795 | $29.79 | $4.5M | 8,990,566 |
Page 3 of 12 · 225 trades